Search
for
Sort by
Research 751–780 of 1000+
- Iron Deficiency in Immune-Mediated Inflammatory Skin Diseases: A Missing Link Between Systemic Inflammation, Immunometabolism, and Disease Burden
- A narrative review of SARS-CoV-2 variants and long COVID
- Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis
- In Vitro Biological Activity and In Vivo Human Study of Porcine-Placenta-Extract-Loaded Nanovesicle Formulations for Skin and Hair Rejuvenation
- Associations between type 1 diabetes and autoimmune skin diseases: Mendelian randomization analysis
- Engineering a 3D wounded skin equivalent to study early inflammatory and regenerative responses in vitro
- Programmed nanozyme hydrogel enabling spatiotemporal modulation of wound healing achieves skin regeneration after biofilm infection
- Involvement of hair follicles in skin tumorigenesis, skin homeostasis and wound healing
- Intravital imaging of host–parasite interactions in skin and adipose tissues
- Genetic Variants and Protective Immunity against SARS-CoV-2
- Microneedles as transdermal drug delivery system for enhancing skin disease treatment
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Fibrotic enzymes modulate wound‐induced skin tumorigenesis
- Chikungunya virus infection in the skin: histopathology and cutaneous immunological response
- Histological and molecular restoration of type VII collagen in Recessive dystrophic epidermolysis bullosa mouse skin by topical injection of keratinocyte-like cells differentiated from human adipose-derived mesenchymal stromal cells
- Adenosine and Its Receptors in the Pathogenesis and Treatment of Inflammatory Skin Diseases
- 608 A clinical study to test the efficacy of VB1953 in clindamycin non-responder acne patients with antibiotic-resistant P. acnes
- Nucleic acid-induced chemokine expression in keratinocytes: Implications for skin inflammation
- Microneedle-Mediated Transdermal Drug Delivery for the Treatment of Multiple Skin Diseases
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions
- Adverse Reactions to Oral Retinoids An Update
- Genetically predicted levels of circulating cytokines and the risk of six immune skin diseases: a two-sample Mendelian randomization study
- Tp63-expressing adult epithelial stem cells cross lineages boundaries revealing latent hairy skin competence
- The therapeutic efficacy of mesenchymal stem cells and their extracellular vesicles in the treatment of diverse skin diseases
- Protein Kinase Cε, which Sensitizes Skin to Sun's UV Radiation–Induced Cutaneous Damage and Development of Squamous Cell Carcinomas, Associates with Stat3
- Clinical Application of Development of Nonantibiotic Macrolides That Correct Inflammation-Driven Immune Dysfunction in Inflammatory Skin Diseases
- Screening of microRNA and mRNA related to secondary hair follicle morphogenesis and development and functional analysis in cashmere goats
- Evaluation of COVID-19 risk in patients on systemic retinoid therapy
- The Anti-atopic Lotions Containing Fucoidan Extracted from Ecklonia Cava Impact on Hairless Mice Atopic Dermatitis Skin
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study